Conference Coverage
ReachMD brings you the latest research, announcements, and conversations from the most important medical conferences around the world. Join us on the conference floor with keynote speakers, experts, and opinion leaders.
Episodes 31-45 of 324
Long-term improvements in daily steps with gamification and financial incentives in patients at risk for CV events
ACC Action CenterLong-term improvements in daily steps with gamification and financial incentives in patients at risk for CV events
Promising results for self-expanding TAVR device in trial with mostly women
ACC Action CenterPromising results for self-expanding TAVR device in trial with mostly women
Innovations in Adherence: Long-Acting Agents for Infectious Diseases
Clinician's RoundtableInnovations in Adherence: Long-Acting Agents for Infectious Diseases
Angiotensinogen RNAi therapeutic lowers blood pressure in combination with standard antihypertensive
ACC Action CenterAngiotensinogen RNAi therapeutic lowers blood pressure in combination with standard antihypertensive
Climate Change and Neurological Infections: The Effects Over Time
NeuroFrontiersClimate Change and Neurological Infections: The Effects Over Time
Preventive PCI versus optimal medical therapy only for vulnerable plaques
ACC Action CenterPreventive PCI versus optimal medical therapy only for vulnerable plaques
Managing Internal Medicine Issues in Hospitalized Neurological Patients
NeuroFrontiersManaging Internal Medicine Issues in Hospitalized Neurological Patients
Uncovering a Potential Biomarker for Myasthenia Gravis
NeuroFrontiersUncovering a Potential Biomarker for Myasthenia Gravis
Maternal Stroke: Causes, Risks, and Care in Pregnancy and Postpartum
NeuroFrontiersMaternal Stroke: Causes, Risks, and Care in Pregnancy and Postpartum
Self-assessment on statin eligibility without prescription using a web app
ACC Action CenterSelf-assessment on statin eligibility without prescription using a web app
Increasing the use of SGLT2i and GLP-1RA with a remote program in T2D and high CV or kidney risk
ACC Action CenterIncreasing the use of SGLT2i and GLP-1RA with a remote program in T2D and high CV or kidney risk
Promising results for APOC3 ASO in familial chylomicronemia syndrome
ACC Action CenterPromising results for APOC3 ASO in familial chylomicronemia syndrome
Recognizing and Addressing Medical Gaslighting in Healthcare
NeuroFrontiersRecognizing and Addressing Medical Gaslighting in Healthcare
More than 70% lowering of triglycerides with APOC3 RNAi in patients with severe hypertriglyceridemia
ACC Action CenterMore than 70% lowering of triglycerides with APOC3 RNAi in patients with severe hypertriglyceridemia
APOC3 ASO significantly lowers triglycerides in patients with hypertriglyceridemia and high CV risk
ACC Action CenterAPOC3 ASO significantly lowers triglycerides in patients with hypertriglyceridemia and high CV risk
